Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 "Breakthrough" drugs and growth in expenditure on prescription drugs in Canada.

Authors: Cynthia A Jackevicius; Jafna L Cox; Daniel Carreon; Jack V Tu; Stéphane Rinfret; Derek So; Helen Johansen; Dimitri Kalavrouziotis; Virginie Demers; Karin Humphries; Louise Pilote
Journal: CMAJ Date: 2009-07-07 Impact factor: 8.262

5. Statin prescribing in Northern Ireland and England pre and post introduction of the quality and outcomes framework.

Authors: Ibrahim Alabbadi; Grainne Crealey; Kathryn Turner; Therese Rafferty; Lynn Keenan; Penny Murray; James C McElnay
Journal: Pharm World Sci Date: 2009-10-31

6. UK medicines policy: the role of clinical pharmacologists.

Authors: David J Webb
Journal: Br J Clin Pharmacol Date: 2012-06 Impact factor: 4.335

7. The fuzzy line between needs, coverage, and excess in the Mexican Formulary List: an example of qualitative market width analysis.

Authors: Israel Rico-Alba; Albert Figueras
Journal: Eur J Clin Pharmacol Date: 2012-10-23 Impact factor: 2.953

8. What is the value of 'me-too' drugs?

Authors: Stephane Régnier
Journal: Health Care Manag Sci Date: 2013-02-26

9. The evolution of Reference Drug Lists and Clinical Practice Guidelines in the public health system of a middle-income country.

Authors: Israel Rico-Alba; Albert Figueras
Journal: Br J Clin Pharmacol Date: 2014-08 Impact factor: 4.335

10. We need a "made in Canada" orphan drug framework.

Authors: Hugh J McMillan; Craig Campbell
Journal: CMAJ Date: 2017-10-16 Impact factor: 8.262